Indivior Pharmaceuticals Inc logo

Indivior Pharmaceuticals Inc

NEW
NAS:INDV (USA)   Ordinary Share
$ 39.8 -0.45 (-1.12%) 12:08 AM EST
20.41
P/B:
0
Market Cap:
$ 4.70B
Enterprise V:
$ 5.04B
Volume:
1.49M
Avg Vol (2M):
2.04M
Warning! GuruFocus detected 3 Severe warning signs with INDV. Try a 7-Day Free Trial to check it out.
Trade In:
Volume:
1.49M
Market Cap $:
4.70B
20.41
Avg Vol (2M):
2.04M
Enterprise Value $:
5.04B
PB Ratio:
0
What is a stock summary page? Click here for an overview. Powered by GuruAPI
Website SEC Filings Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocksâ„¢

INDV Stock Historical Dividends and Yields -Indivior Pharmaceuticals Inc

Indivior Pharmaceuticals Inc (INDV) pays a dividend yield of 0%. The 5-year dividend growth rate is 0%. Indivior Pharmaceuticals Inc has been paying dividends since 2015.

Below is Indivior Pharmaceuticals Inc's complete dividend history, ex-dividend dates, payout ratio trends, and dividend yield charts.

Dividend started since

 
2015

Years of Dividend History

 
11
0% (Trailing)
0% (Forward)

Dividend Yield

0
 

Dividend Payout Ratio

0%
 

Growth Rate (5-Year)

0%
 

Yield on Cost (5-Year)

-65.6%
 

3-Year Share Buyback Ratio

* Special dividend is not included in the calculation of dividend per share and related fields

Dividend Growth


Indivior Pharmaceuticals Inc Dividend History & Ex-Dividend Dates

Complete history of 2 dividend payments by Indivior Pharmaceuticals Inc since 2015. Each row shows the ex-dividend date, amount per share, record date, pay date, and declaration date.

Indivior Pharmaceuticals Inc (INDV) Dividend History
Ex-Dividend Date Amount Record Date Pay Date Declaration Date
2016-06-16 USD 0.475 2016-06-17 2016-07-29 2016-02-18
2015-09-17 USD 0.16 2015-09-18 2015-10-23 2015-07-29

Frequently Asked Questions: INDV Dividend

Does Indivior Pharmaceuticals Inc (INDV) pay a dividend?

Indivior Pharmaceuticals Inc (INDV) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Indivior Pharmaceuticals Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Indivior Pharmaceuticals Inc has returned capital to shareholders via buybacks at a rate of -65.6% over the past 3 years.

What are dividend-paying alternatives to Indivior Pharmaceuticals Inc?

For dividend-paying alternatives in Indivior Pharmaceuticals Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.

Also check out

High Yield Dividend Stocks in Gurus' Portfolio
Top dividend stocks of Warren Buffett
Top dividend stocks of George Soros
All-in-one Screener
Screen For High Dividend Stocks

Dividend Yield History

This is the historical trailing annual dividend yield of Indivior Pharmaceuticals Inc. Buying stocks at higher yield relative its historical values is usually more profitable.

Dividend Per Share History

This the dividend history of Indivior Pharmaceuticals Inc

Dividend Payout Ratio

This is the historical payout ratio of Indivior Pharmaceuticals Inc. If the dividend payout ratio is close to or higher than 1, dividends might not be sustainable.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文
Education
Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2026 GuruFocus.com, LLC. All Rights Reserved.